Publication | Closed Access

Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: Sub-analysis of a Phase IV open-label trial in Chinese patients

ObesityMetabolic SyndromeDiabetes ManagementGlobal HealthDiabetesBody Mass IndexGastroenterologyType 2Diabetes MellitusMedicineExtended-release MetforminHealth Sciences